The RA-MAP Consortium: a working model for academia-industry collaboration

Research output: Contribution to journalReview articlepeer-review

Standard

The RA-MAP Consortium : a working model for academia-industry collaboration. / Cope, Andrew P; Barnes, Michael R; Belson, Alexandra; Binks, Michael; Brockbank, Sarah; Bonachela-Capdevila, Francisco; Carini, Claudio; Fisher, Benjamin A; Goodyear, Carl S; Emery, Paul; Ehrenstein, Michael R; Gozzard, Neil; Harris, Ray; Hollis, Sally; Keidel, Sarah; Levesque, Marc; Lindholm, Catharina; McDermott, Michael F; McInnes, Iain B; Mela, Christopher M; Parker, Gerry; Read, Simon; Pedersen, Ayako Wakatsuki; Ponchel, Frederique; Porter, Duncan; Rao, Ravi; Rowe, Anthony; Schulz-Knappe, Peter; Sleeman, Matthew A; Symmons, Deborah; Taylor, Peter C; Tom, Brian; Tsuji, Wayne; Verbeeck, Denny; Isaacs, John D; RA-MAP Consortium ; Young, Stephen.

In: Nature Reviews Rheumatology, Vol. 14, No. 1, 07.12.2017, p. 53-60.

Research output: Contribution to journalReview articlepeer-review

Harvard

Cope, AP, Barnes, MR, Belson, A, Binks, M, Brockbank, S, Bonachela-Capdevila, F, Carini, C, Fisher, BA, Goodyear, CS, Emery, P, Ehrenstein, MR, Gozzard, N, Harris, R, Hollis, S, Keidel, S, Levesque, M, Lindholm, C, McDermott, MF, McInnes, IB, Mela, CM, Parker, G, Read, S, Pedersen, AW, Ponchel, F, Porter, D, Rao, R, Rowe, A, Schulz-Knappe, P, Sleeman, MA, Symmons, D, Taylor, PC, Tom, B, Tsuji, W, Verbeeck, D, Isaacs, JD, RA-MAP Consortium & Young, S 2017, 'The RA-MAP Consortium: a working model for academia-industry collaboration', Nature Reviews Rheumatology, vol. 14, no. 1, pp. 53-60. https://doi.org/10.1038/nrrheum.2017.200

APA

Cope, A. P., Barnes, M. R., Belson, A., Binks, M., Brockbank, S., Bonachela-Capdevila, F., Carini, C., Fisher, B. A., Goodyear, C. S., Emery, P., Ehrenstein, M. R., Gozzard, N., Harris, R., Hollis, S., Keidel, S., Levesque, M., Lindholm, C., McDermott, M. F., McInnes, I. B., ... Young, S. (2017). The RA-MAP Consortium: a working model for academia-industry collaboration. Nature Reviews Rheumatology, 14(1), 53-60. https://doi.org/10.1038/nrrheum.2017.200

Vancouver

Cope AP, Barnes MR, Belson A, Binks M, Brockbank S, Bonachela-Capdevila F et al. The RA-MAP Consortium: a working model for academia-industry collaboration. Nature Reviews Rheumatology. 2017 Dec 7;14(1):53-60. https://doi.org/10.1038/nrrheum.2017.200

Author

Cope, Andrew P ; Barnes, Michael R ; Belson, Alexandra ; Binks, Michael ; Brockbank, Sarah ; Bonachela-Capdevila, Francisco ; Carini, Claudio ; Fisher, Benjamin A ; Goodyear, Carl S ; Emery, Paul ; Ehrenstein, Michael R ; Gozzard, Neil ; Harris, Ray ; Hollis, Sally ; Keidel, Sarah ; Levesque, Marc ; Lindholm, Catharina ; McDermott, Michael F ; McInnes, Iain B ; Mela, Christopher M ; Parker, Gerry ; Read, Simon ; Pedersen, Ayako Wakatsuki ; Ponchel, Frederique ; Porter, Duncan ; Rao, Ravi ; Rowe, Anthony ; Schulz-Knappe, Peter ; Sleeman, Matthew A ; Symmons, Deborah ; Taylor, Peter C ; Tom, Brian ; Tsuji, Wayne ; Verbeeck, Denny ; Isaacs, John D ; RA-MAP Consortium ; Young, Stephen. / The RA-MAP Consortium : a working model for academia-industry collaboration. In: Nature Reviews Rheumatology. 2017 ; Vol. 14, No. 1. pp. 53-60.

Bibtex

@article{6a51cdcb14c64ffeab3cef73e50e3874,
title = "The RA-MAP Consortium: a working model for academia-industry collaboration",
abstract = "Collaboration can be challenging; nevertheless, the emerging successes of large, multi-partner, multi-national cooperatives and research networks in the biomedical sector have sustained the appetite of academics and industry partners for developing and fostering new research consortia. This model has percolated down to national funding agencies across the globe, leading to funding for projects that aim to realise the true potential of genomic medicine in the 21st century and to reap the rewards of 'big data'. In this Perspectives article, the experiences of the RA-MAP consortium, a group of more than 140 individuals affiliated with 21 academic and industry organizations that are focused on making genomic medicine in rheumatoid arthritis a reality are described. The challenges of multi-partner collaboration in the UK are highlighted and wide-ranging solutions are offered that might benefit large research consortia around the world.",
keywords = "Arthritis, Rheumatoid, Biomarkers, Biomedical Research, Cooperative Behavior, Genomics, History, 21st Century, Humans, Industry, Phenotype, Research, United Kingdom, Historical Article, Journal Article, Review",
author = "Cope, {Andrew P} and Barnes, {Michael R} and Alexandra Belson and Michael Binks and Sarah Brockbank and Francisco Bonachela-Capdevila and Claudio Carini and Fisher, {Benjamin A} and Goodyear, {Carl S} and Paul Emery and Ehrenstein, {Michael R} and Neil Gozzard and Ray Harris and Sally Hollis and Sarah Keidel and Marc Levesque and Catharina Lindholm and McDermott, {Michael F} and McInnes, {Iain B} and Mela, {Christopher M} and Gerry Parker and Simon Read and Pedersen, {Ayako Wakatsuki} and Frederique Ponchel and Duncan Porter and Ravi Rao and Anthony Rowe and Peter Schulz-Knappe and Sleeman, {Matthew A} and Deborah Symmons and Taylor, {Peter C} and Brian Tom and Wayne Tsuji and Denny Verbeeck and Isaacs, {John D} and {RA-MAP Consortium} and Stephen Young",
year = "2017",
month = dec,
day = "7",
doi = "10.1038/nrrheum.2017.200",
language = "English",
volume = "14",
pages = "53--60",
journal = "Nature Reviews Rheumatology",
issn = "1759-4790",
publisher = "Nature Publishing Group",
number = "1",

}

RIS

TY - JOUR

T1 - The RA-MAP Consortium

T2 - a working model for academia-industry collaboration

AU - Cope, Andrew P

AU - Barnes, Michael R

AU - Belson, Alexandra

AU - Binks, Michael

AU - Brockbank, Sarah

AU - Bonachela-Capdevila, Francisco

AU - Carini, Claudio

AU - Fisher, Benjamin A

AU - Goodyear, Carl S

AU - Emery, Paul

AU - Ehrenstein, Michael R

AU - Gozzard, Neil

AU - Harris, Ray

AU - Hollis, Sally

AU - Keidel, Sarah

AU - Levesque, Marc

AU - Lindholm, Catharina

AU - McDermott, Michael F

AU - McInnes, Iain B

AU - Mela, Christopher M

AU - Parker, Gerry

AU - Read, Simon

AU - Pedersen, Ayako Wakatsuki

AU - Ponchel, Frederique

AU - Porter, Duncan

AU - Rao, Ravi

AU - Rowe, Anthony

AU - Schulz-Knappe, Peter

AU - Sleeman, Matthew A

AU - Symmons, Deborah

AU - Taylor, Peter C

AU - Tom, Brian

AU - Tsuji, Wayne

AU - Verbeeck, Denny

AU - Isaacs, John D

AU - RA-MAP Consortium

AU - Young, Stephen

PY - 2017/12/7

Y1 - 2017/12/7

N2 - Collaboration can be challenging; nevertheless, the emerging successes of large, multi-partner, multi-national cooperatives and research networks in the biomedical sector have sustained the appetite of academics and industry partners for developing and fostering new research consortia. This model has percolated down to national funding agencies across the globe, leading to funding for projects that aim to realise the true potential of genomic medicine in the 21st century and to reap the rewards of 'big data'. In this Perspectives article, the experiences of the RA-MAP consortium, a group of more than 140 individuals affiliated with 21 academic and industry organizations that are focused on making genomic medicine in rheumatoid arthritis a reality are described. The challenges of multi-partner collaboration in the UK are highlighted and wide-ranging solutions are offered that might benefit large research consortia around the world.

AB - Collaboration can be challenging; nevertheless, the emerging successes of large, multi-partner, multi-national cooperatives and research networks in the biomedical sector have sustained the appetite of academics and industry partners for developing and fostering new research consortia. This model has percolated down to national funding agencies across the globe, leading to funding for projects that aim to realise the true potential of genomic medicine in the 21st century and to reap the rewards of 'big data'. In this Perspectives article, the experiences of the RA-MAP consortium, a group of more than 140 individuals affiliated with 21 academic and industry organizations that are focused on making genomic medicine in rheumatoid arthritis a reality are described. The challenges of multi-partner collaboration in the UK are highlighted and wide-ranging solutions are offered that might benefit large research consortia around the world.

KW - Arthritis, Rheumatoid

KW - Biomarkers

KW - Biomedical Research

KW - Cooperative Behavior

KW - Genomics

KW - History, 21st Century

KW - Humans

KW - Industry

KW - Phenotype

KW - Research

KW - United Kingdom

KW - Historical Article

KW - Journal Article

KW - Review

U2 - 10.1038/nrrheum.2017.200

DO - 10.1038/nrrheum.2017.200

M3 - Review article

C2 - 29213124

VL - 14

SP - 53

EP - 60

JO - Nature Reviews Rheumatology

JF - Nature Reviews Rheumatology

SN - 1759-4790

IS - 1

ER -